(June 14, 2024, 2:04 PM EDT) -- DALLAS — A federal judge in Texas dismissed a biopharmaceutical company’s complaint against certain of its own investors, alleging that they issued false statements in an attempt to elect outside director candidates onto the company’s board, finding that the company lacked standing to bring certain federal securities claims as the issuer of the stock in question and that other claims were mooted by the investors filing amended disclosure statements....